WHO Grants Emergency Use Listing for Cepheid's Xpert® Hemorrhagic Fever Panel Test to Support Ebola Outbreak Response in the DRC
Go back to WHO Grants Emergency Use Listing for Cepheid's Xpert® Hemorrhagic Fever Panel Test to Support Ebola Outbreak Response in the DRC| Danaher Corp. (NYSE: DHR) | Delayed: 204.94 -0.29 (0.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $205.23 | 52 Week High | $102.79 | |||
| Open | $206.00 | 52 Week Low | $75.71 | |||
| Day High | $206.05 | P/E | 53.93 | |||
| Day Low | $201.95 | EPS | $3.80 | |||
| Volume | 1,402,067 | |||||
